<DOC>
<DOCNO>EP-0649419</DOCNO> 
<TEXT>
<INVENTION-TITLE>
N-CYCLOALKYLPIPERAZINE DERIVATIVES, METHODS OF OBTAINING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K31495	A61K31495	A61P900	A61P912	A61P2500	A61P2504	A61P2520	A61P2524	A61P2526	A61P4300	A61P4300	C07D29500	C07D29512	C07D29513	C07D29514	C07D29515	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61K	A61P	A61P	A61P	A61P	A61P	A61P	A61P	A61P	A61P	C07D	C07D	C07D	C07D	C07D	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K31	A61K31	A61P9	A61P9	A61P25	A61P25	A61P25	A61P25	A61P25	A61P43	A61P43	C07D295	C07D295	C07D295	C07D295	C07D295	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
N-cyclopiperazine derivatives of formula (I) in which A is an amide grouping, (a) or (b), R1, R2, R3, R4 and/or R5 are the same or different and represent a hydrogen atom, a halogen atom, a C1-C6 alkyl group, a C1-C6 alkoxy group, a trifluoromethyl grouping or a benzene ring, m is an integer from 1 to 3, n is the integer 2 or 3. These compounds are useful for preparing medicaments acting on the central nervous system, particularly as neuroleptics, or as pharmacological reagents.
</ABSTRACT>
<APPLICANTS>
<APPLICANT-NAME>
MERAM LAB
</APPLICANT-NAME>
<APPLICANT-NAME>
LES LABORATOIRES MERAM
</APPLICANT-NAME>
</APPLICANTS>
<INVENTORS>
<INVENTOR-NAME>
EL AHMAD YOUSSEF
</INVENTOR-NAME>
<INVENTOR-NAME>
LAURENT ELISABETH
</INVENTOR-NAME>
<INVENTOR-NAME>
OLLIVIER ROLAND
</INVENTOR-NAME>
<INVENTOR-NAME>
TALAB AKRAM
</INVENTOR-NAME>
<INVENTOR-NAME>
TRAN GILLES
</INVENTOR-NAME>
<INVENTOR-NAME>
EL AHMAD, YOUSSEF
</INVENTOR-NAME>
<INVENTOR-NAME>
LAURENT, ELISABETH
</INVENTOR-NAME>
<INVENTOR-NAME>
OLLIVIER, ROLAND
</INVENTOR-NAME>
<INVENTOR-NAME>
TALAB, AKRAM
</INVENTOR-NAME>
<INVENTOR-NAME>
TRAN, GILLES
</INVENTOR-NAME>
</INVENTORS>
</TEXT>
</DOC>
